Applications
News & Events
Contact
Viral Vector R&D and Industrialization Platforms Viral Vector R&D and Industrialization Platforms
Cell Therapy Manufacturing Solutions Cell Therapy Manufacturing Solutions
Interdisciplinary R&D Platforms Interdisciplinary R&D Platforms

Platforms

Viral Vector R&D and Industrialization Platforms

With a focus on pioneering research in the CGT industry, EurekaBio strives to address unresolved core viral vector production challenges.

EuLV™ System

Solutions

Cell Therapy Manufacturing Solutions

EurekaBio offers comprehensive solutions for the preparation and production of cell therapy products, driving cost reduction and enhancing efficiency within the CGT industry.

CellSep™ PRO CellSep™ MAX

Platforms

Interdisciplinary R&D Platforms

By integrating automation and biotechnology, EurekaBio designs and builds automated platforms for biological research and development projects.

EuBioX System

Application

Learn More

Lentiviral Vector

The EuBioX bio-automation system, play a vital role in advancing the EuLV™ stable lentiviral vector system, especially during the phase of high-throughput monoclonal screening in the development of EuLV™ stable producer cell lines.
EuBioX System EuLV™ System
We are always here to assist.

News Center

Learn More

2024.03.07

EurekaBio Completes $40 Million Series B+ Financing to Advance EuLV™ Lentiviral Vector Production System

2023.11.23

Congratulations to CorreGene on the IND approval of CRTE7A2-01 TCR-T cell injection!

2023.08.10

Connect with EurekaBio At 2023 CAR-TCR Summit

2023.05.07

A Delegation from the Cell and Gene Therapy Product Regulation Research Committee under the China Society for Drug Regulation Visits EurekaBio for Research and Guidance

2023.05.06

EurekaBio Secures Two Awards of “2023 Future Healthcare VB100”

2023.04.18

EurekaBio Facilitating IND Application Filings and Advancing the Commercialization of CGT Drugs

2023.03.17

Terumo BCT and EurekaBio Reach a Strategic Partnership to Jointly Establish Platform for Cell Therapy Process Development

2023.03.15

EurekaBio Accredited as a “Specialized and Sophisticated Enterprise that Produces Novel and Unique Products” in Shenzhen
Footer

Our story starts here…..

© 2023 Shenzhen Eureka Biotechnology Co., Limited. Privacy Policy

Viral Vector R&D and Industrialization Platforms

EuLV™ System

Cell Therapy Manufacturing Solution

CellSep™ PRO

CellSep™ MAX

Applications News & Events Careers About Us

Interdisciplinary R&D Platforms

EuBioX System

Contact